MarginsXMarginsX
Home › Data Desk › Trevi Therapeutics Inc. reports $27.8M of cash, about 5.4 months at its recent burn

MarginsX Data Desk · Quarterly results · Late-stage clinical trials · FDA approval · Warrants and inducements

Trevi Therapeutics Inc. reports $27.8M of cash, about 5.4 months at its recent burn

Trevi Therapeutics Inc. (TRVI) filed its 10-Q on Nov 9, 2026, covering the quarter ended Sep 30, 2026. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 9, 2026.

Line chart of Trevi Therapeutics Inc. (TRVI) daily closes from Jul 2, 2026 to Nov 9, 2026, with the results filing on Nov 9, 2026 marked.

Revenue and margins

The net loss was $21.5M. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

Balance sheet

Cash was $27.8M at Sep 30, 2026, against $54.3M at Jun 30, 2026. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

Shares outstanding were 142.6 million, against 142.5 million at Jun 30, 2026, a rise of 0.1%. (SEC XBRL company facts, 10-Q, Nov 9, 2026)

At its recent quarterly burn of $15.4M, that cash lasts about 5.4 months, by our estimate from its XBRL cash flows. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

The stock

The Nasdaq screener puts its market value at $1.9B. (Nasdaq stock screener, Nov 13, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/TRVI)

The filing on SEC EDGAR. (sec.gov)

The filing in the MarginsX reader. (MarginsX reader)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameTrevi Therapeutics Inc.Source2026-11-13
Cash27,849,000 USDSource2026-09-30
Runway5.4 monthsSource2026-09-30
WhoTrevi Therapeutics Inc. (TRVI)Source2026-11-13
SymbolTRVISource2026-11-13
Form10-QSource2026-11-09
FiledNov 9, 2026Source2026-11-09
Period endSep 30, 2026Source2026-11-09
Net loss21,452,000 USDSource2026-11-09
Net income-21,452,000 USDSource2026-11-09
Cash prior54,302,000 USDSource2026-08-06
Prior endJun 30, 2026Source2026-08-06
Shares142,559,400 sharesSource2026-11-09
Shares prior142,475,841 sharesSource2026-08-06
Dilution0.001 %Source2026-11-09
Burn abs15,359,000 USDSource2026-09-30
Burn-15,359,000 USDSource2026-09-30
Cap1,941,659,028 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS